Columbus Venture Partners logo

Columbus Venture Partners

Europe, Madrid, Spain, Madrid

Description

Columbus Venture Partners is an independent venture capital that invests in early-stage opportunities in the life science industry.

Investor Profile

Columbus Venture Partners has backed more than 17 startups, with 4 new investments in the last 12 months alone. The firm has led 11 rounds, about 65% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in Spain, United States, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.
  • Led 3 rounds in the past year.

Stage Focus

  • Series Unknown (35%)
  • Series A (18%)
  • Series C (18%)
  • Series B (12%)
  • Convertible Note (6%)
  • Series D (6%)
  • Seed (6%)

Country Focus

  • Spain (47%)
  • United States (24%)
  • United Kingdom (12%)
  • France (6%)
  • Israel (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Alternative Protein
  • Food Processing
  • Nutrition
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Columbus Venture Partners frequently co-invest with?

Sangha Capital
Europe, Geneve, Switzerland, Genève
Co-Investments: 2
CV
North America, Massachusetts, United States, Boston
Co-Investments: 2
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 5
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 7
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
CC
Europe, Madrid, Spain, Madrid
Co-Investments: 2
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 2
North South Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Sound Bioventures
Europe, Skane Lan, Sweden, Malmö
Co-Investments: 3
Co-Investments: 4

Which angels does Columbus Venture Partners often collaborate with?

BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 2

What are some of recent deals done by Columbus Venture Partners?

Accipiter Biosciences

Seattle, Washington, United States

Accipiter Biosciences is a biotechnology company.

BiotechnologyLife Science
SeedNov 6, 2025
Amount Raised: $12,700,000
ARTHEx Biotech

Valencia, Comunidad Valenciana, Spain

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Biotechnology
Series BSep 17, 2025
Amount Raised: $40,640,000
Integra Therapeutics

Barcelona, Catalonia, Spain

Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.

BiotechnologyGeneticsHealth Care
SeedSep 8, 2025
Amount Raised: $12,541,948
DeepUll

Barcelona, Catalonia, Spain

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

BiotechnologyLife Science
Series CApr 29, 2025
Amount Raised: $57,074,303
Lutris Pharma

Tel Aviv-yafo, Tel Aviv, Israel

Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.

BiotechnologyFirst AidHealth CareWellness
Series UnknownJan 28, 2025
Amount Raised: $30,000,000

Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.

Biotechnology
SeedOct 15, 2024
Amount Raised: $20,200,000
Artax Biopharma

Cambridge, Massachusetts, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Convertible NoteAug 6, 2024
Amount Raised: $8,000,000
Multiverse Computing

Donostia-san Sebastián, Pais Vasco, Spain

Multiverse Computing is a quantum software company that applies advanced solutions to solve complex challenges.

Machine LearningQuantum ComputingSoftware
Series AMar 5, 2024
Amount Raised: $27,139,723
Curve Therapeutics

Southampton, Southampton, United Kingdom

Curve develops an innovative screening platform.

Biotechnology
Series AFeb 27, 2024
Amount Raised: $51,355,077
Cocoon Bioscience

Madrid, Madrid, Spain

Cocoon Bioscience produces recombinant proteins and enzymes for individual protein, nutrition, and healthcare applications.

Alternative ProteinBiotechnologyFood ProcessingNutrition
Series UnknownNov 3, 2023
Amount Raised: $2,147,190